Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up

Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up

Approximately 20% of patients with ulcerative colitis (UC) develop acute severe UC (ASUC), for which intravenous systemic steroid therapy and possibly infliximab-based rescue therapy are generally imposed. However, there are no significant guideline recommendations on ASUC regarding vedolizumab as a...

Full description

Bibliographic Details
Main Authors: Raffaele Pellegrino, Morena Fasano, Floriana Morgillo, Giovanna Palladino, Isabella Vassallo, Mario Pirozzi, Giuseppe Imperio, Salvatore Auletta, Andrea Ventura, Iacopo Panarese, Alessandro Federico, Antonietta Gerarda Gravina
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Gastrointestinal Disorders
Subjects:
ulcerative colitis
inflammatory bowel disease
acute severe ulcerative colitis
chemotherapy
lung cancer
Online Access:https://www.mdpi.com/2624-5647/5/3/30

Internet

https://www.mdpi.com/2624-5647/5/3/30

Similar Items